Nanoparticle Targeting to Control Angiogenesis
Nanoparticle Targeting to Control Angiogenesis
批准号:
7084418
负责人:
Jeffrey M. Davidson
金额:
$30.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-22 至 2008-07-31
关键词:
SDS polyacrylamide gel electrophoresisangiogenesisapolipoprotein Eautoradiographybioimaging /biomedical imagingbiomaterial development /preparationbiotechnologycell linedrug delivery systemsdrug vehicleenzyme linked immunosorbent assayfluorescence microscopyimaging /visualization /scanningimmunocytochemistrylaboratory mouselungmagnetic resonance imagingneoplasm /cancerpeptidespharmacokineticsthrombospondinsultrasonographywound
中文摘要
描述(由申请人提供):该项目的目标是实现血管抑制剂靶向递送到新生血管的部位。这是一种被广泛接受的策略,但部分受到交付和验证技术的限制。拟议的研究围绕着一种新的、生物相容性的递送装置——纳米颗粒(NP),作为一种手段,提供持续的、靶向的血管抑制剂递送到血管生成部位:伤口和肿瘤。该递送系统的关键要素是低毒性和基于带电聚合物对相互作用的组分柔韧性。作为一个模型系统,我们利用了新的肽类似物血栓反应蛋白-1 (TSP-1)先前显示具有血管抑制特性。为了在NP中提供保留,这些肽被制备成聚乙二醇偶联物,既保留肝素结合又保留生物活性。与空NP相比,用TSP-1肽偶联物制备的NP具有明显不同的生物分布和新血管形成部位的定位。本研究旨在实现三个目标:(1)优化NP制剂,包括剂量设置和其他靶向药物的结合;(2)利用成像和示踪技术确定靶向NP在小鼠体内的生物分布;(3)验证含有血管抑制剂的NP靶向递送到伤口和肿瘤的有效性。在进一步的研究中,载脂蛋白E衍生的肽序列将被整合到纳米颗粒中,以增强内皮细胞的选择性靶向。肿瘤的传递和靶向性将通过荧光素酶生物发光、123i成像和钆造影剂磁共振成像等无创成像技术进行测试。传统的示踪技术和荧光标记NP的显微定位也将被应用。在体内,将通过功率多普勒超声确定肿瘤血管的实时图像分析,并通过磁共振成像确定肿瘤肿块。此外,传统的形态计量学和组织学技术将用于量化这种新型药物输送系统的功效。目的是设计药物输送系统,以病理血管生成为目标,对正常血管系统的影响最小。
英文摘要
DESCRIPTION (provided by applicant): The goal of this project is to achieve targeted delivery of angiostatic agents to sites of neovascularization. This is a widely accepted strategy that is limited in part by technologies of delivery and validation. The proposed studies center around a novel, biocompatible delivery device, the nanoparticle (NP), as a means to provide sustained, targeted delivery of angiostatic agents to sites of angiogenesis: wounds and tumors. The key elements of the delivery system are low toxicity and compositional flexibility, based interactions of charged polymer pairs. As a model system, we have utilized novel peptide analogs of thrombospondin-l (TSP-1) previously shown to have angiostatic properties. To provide retention within NP, these peptides have been prepared as polyethylene glycol conjugates that retain both heparin binding and biological activity. NP prepared with TSP-1 peptide conjugates show a markedly different biodistribution than empty NP and localization to sites of neovascularization. This proposal sets out to accomplish three goals: (1) optimization of the NP formulation, including dose-setting and incorporation of other targeting agents; (2) use of imaging and tracer technologies to ascertain biodistribution of targeted NP in mice; (3) validation of the efficacy of targeted delivery of NP containing angiostatic agents to wounds and tumors. In further studies, a peptide sequence derived from apolipoprotein E will be incorporated into the nanoparticle to enhance selective targeting of endothelial cells. Tumor delivery and targeting will be tested by noninvasive imaging using luciferase bioluminescence, 123I-scintigraphic imaging, and magnetic resonance imaging with gadolinium contrast. Conventional tracer technologies and microscopic localization of fluorescently labeled NP will be applied as well. In vivo, real-time image analysis of tumor vascularity will be determined by power Doppler ultrasound, and tumor mass will be determined by magnetic resonance imaging. In addition, conventional morphometric and histological techniques will be used to quantify the efficacy of this novel drug delivery system. The objective is to design drug delivery systems that will specifically target pathological angiogenesis with minimal effects on the normal vasculature.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/jps.21270
发表时间:
2008-09
期刊:
JOURNAL OF PHARMACEUTICAL SCIENCES
影响因子:
3.8
作者:
[Prokop, Ales, Davidson, Jeffrey M.]
通讯作者:
Davidson, Jeffrey M.
Nanoparticulate system for efficient gene transfer into refractory cell targets.
用于将基因有效转移至难治性细胞靶标的纳米颗粒系统。
DOI:
10.1021/bm0492531
发表时间:
2005
期刊:
Biomacromolecules.
影响因子:
--
作者:
[Carlesso,Gianluca, Kozlov,Eugene, Prokop,Ales, Unutmaz,Derya, Davidson,JeffreyM]
通讯作者:
Davidson,JeffreyM
Development of improved nanoparticulate polyelectrolyte complex physicochemistry by nonstoichiometric mixing of polyions with similar molecular weights.
通过具有相似分子量的聚离子的非化学计量混合来开发改进的纳米颗粒聚电解质复合物物理化学。
DOI:
10.1021/bm0604754
发表时间:
2007
期刊:
Biomacromolecules
影响因子:
6.2
作者:
[Hartig,SeanM, Carlesso,Gianluca, Davidson,JeffreyM, Prokop,Ales]
通讯作者:
Prokop,Ales
Biennial Meeting of the American Society for Matrix Biology
-
批准号:8399649
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2012
-
负责人:Jeffrey M. Davidson
-
依托单位:
Skin Regeneration with Stem Cells and Scaffolds
-
批准号:8092689
-
项目类别:
-
资助金额:$67.24万
-
财政年份:2009
-
负责人:Jeffrey M. Davidson
-
依托单位:
Skin Regeneration with Stem Cells and Scaffolds
-
批准号:8508674
-
项目类别:
-
资助金额:$60.12万
-
财政年份:2009
-
负责人:Jeffrey M. Davidson
-
依托单位:
Skin Regeneration with Stem Cells and Scaffolds
-
批准号:7741307
-
项目类别:
-
资助金额:$68.83万
-
财政年份:2009
-
负责人:Jeffrey M. Davidson
-
依托单位:
Skin Regeneration with Stem Cells and Scaffolds
-
批准号:8291439
-
项目类别:
-
资助金额:$65.43万
-
财政年份:2009
-
负责人:Jeffrey M. Davidson
-
依托单位:
Skin Regeneration with Stem Cells and Scaffolds
-
批准号:7921567
-
项目类别:
-
资助金额:$72.31万
-
财政年份:2009
-
负责人:Jeffrey M. Davidson
-
依托单位:
Phenotype Core - Core D
-
批准号:7486585
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2007
-
负责人:Jeffrey M. Davidson
-
依托单位:
Annual Meeting of the Wound Healing Society
-
批准号:6771451
-
项目类别:
-
资助金额:$2.45万
-
财政年份:2004
-
负责人:Jeffrey M. Davidson
-
依托单位:
Nanoparticle Targeting to Control Angiogenesis
-
批准号:6917828
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:7586056
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
Nanoparticle Targeting to Control Angiogenesis
-
批准号:6802417
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:7840426
-
项目类别:
-
资助金额:$28.02万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:8101385
-
项目类别:
-
资助金额:$4.21万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:6932025
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:7263448
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
Nanoparticle Targeting to Control Angiogenesis
-
批准号:6735446
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:7393153
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:6703342
-
项目类别:
-
资助金额:$32.73万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:6802786
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
CARP: Angiogenic Gene Therapy in Diabetic Wounds
-
批准号:8047947
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2003
-
负责人:Jeffrey M. Davidson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: